Previous studies have demonstrated the crucial role of the intestinal microbiota in regulating NF-κB expression, a transcription factor involved in the activation of various inflammation-related genes and modulation of which is implicated in the development of several pathologies, including cardiovascular and autoimmune diseases [64]. Here, NFKB1 is linked to autoimmune disease.